BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1657811)

  • 1. Histopathological pattern in prostatic adenocarcinomas: is it a prognostic criterion?
    Bircan K; Başar I; Ergen A; Tekgül S; Ozbay G; Ozen HA
    Int Urol Nephrol; 1991; 23(1):57-64. PubMed ID: 1657811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic adenocarcinoma of ductal origin.
    Dube VE; Farrow GM; Greene LF
    Cancer; 1973 Aug; 32(2):402-9. PubMed ID: 4124700
    [No Abstract]   [Full Text] [Related]  

  • 3. Cribriform and glomeruloid acinar adenocarcinoma of the prostate-an intratumoural intraductal carcinoma?
    Tolkach Y; Kristiansen G
    Histopathology; 2019 May; 74(6):804-808. PubMed ID: 31006895
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraobserver and interobserver reproducibility of WHO and Gleason histologic grading systems in prostatic adenocarcinomas.
    Ozdamar SO; Sarikaya S; Yildiz L; Atilla MK; Kandemir B; Yildiz S
    Int Urol Nephrol; 1996; 28(1):73-7. PubMed ID: 8738623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal carcinoma of the prostate: a critical re-appraisal.
    Varma M; Delahunt B; Egevad L; Samaratunga H; Kristiansen G
    Virchows Arch; 2019 May; 474(5):525-534. PubMed ID: 30825003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
    Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
    Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma.
    Montironi R; Cimadamore A; Gasparrini S; Mazzucchelli R; Santoni M; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M
    Expert Rev Anticancer Ther; 2018 Jul; 18(7):685-693. PubMed ID: 29699428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates on Grading and Staging of Prostate Cancer.
    Braunhut BL; Punnen S; Kryvenko ON
    Surg Pathol Clin; 2018 Dec; 11(4):759-774. PubMed ID: 30447840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with Gleason histopathologic grading of prostatic cancer in Japan.
    Nemoto R; Uchida K; Harada M; Koiso K; Abe R; Kato T
    Urology; 1987 Nov; 30(5):436-40. PubMed ID: 3672676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings.
    Robinson BD; Epstein JI
    J Urol; 2010 Oct; 184(4):1328-33. PubMed ID: 20723921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic adenocarcinoma of ductal origin.
    Greene LF; Farrow GM; Ravits JM; Tomera FM
    J Urol; 1979 Mar; 121(3):303-5. PubMed ID: 219263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
    Billis A; Guimaraes MS; Freitas LL; Meirelles L; Magna LA; Ferreira U
    J Urol; 2008 Aug; 180(2):548-52; discussion 552-3. PubMed ID: 18550106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A histopathological study of carcinoma of the prostate in Port Harcourt, Nigeria.
    Obiorah CC; Nwosu SO
    Niger J Clin Pract; 2011; 14(3):363-7. PubMed ID: 22037086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary adenocarcinoma of prostate.
    Scott MB; Goldstein AM; Onofrio RC; Cosgrove MD
    Urology; 1976 Sep; 8(3):227-30. PubMed ID: 184573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histologic grading of primary prostatic carcinoma--study of Gleason histologic grading].
    Uchijima Y; Kusuyama H; Okada K
    Hinyokika Kiyo; 1987 Aug; 33(8):1193-8. PubMed ID: 3425519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.
    Prendeville S; Gertner M; Maganti M; Pintilie M; Perlis N; Toi A; Evans AJ; Finelli A; van der Kwast TH; Ghai S
    J Urol; 2018 Jul; 200(1):104-113. PubMed ID: 29408568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.
    Turker P; Bas E; Bozkurt S; Günlüsoy B; Sezgin A; Postacı H; Turkeri L
    Urol Oncol; 2013 Jan; 31(1):93-8. PubMed ID: 21316989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.
    Haffner MC; Weier C; Xu MM; Vaghasia A; Gürel B; Gümüşkaya B; Esopi DM; Fedor H; Tan HL; Kulac I; Hicks J; Isaacs WB; Lotan TL; Nelson WG; Yegnasubramanian S; De Marzo AM
    J Pathol; 2016 Jan; 238(1):31-41. PubMed ID: 26331372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.